Together stronger in curing cancer
Finding effective treatments for rare cancer patients, aiming for the highest quality of life
Our mission
Initiating, facilitating and coordinating large-scale collaboration to find effective treatments for rare cancer patients using innovative technology
Our beliefs
Our entrepreneurial and tech background has learned us that we are most successful when we:
Our focus
Bringing together a multi-disciplinary community consisting of medical & research institutions, NGOs and other organisations to drive patient impact. We do this via:
Knowledge & data sharing
Partner events to exchange expertise and drive multi-disciplinary collaboration
Developing clinical trials
Prospective and exploratory (biomedical) studies designed to answer specific research questions
Fundraising
Grant support initiatives to fund scientific research that focuses on primarily rare types of cancer
Yamicc is orchestrating a data-driven research platform that focuses on easily and securely collecting, processing, and sharing all relevant information. Our platform, called DataBridge, is focused on cost effectively supporting large scale scientific research for rare cancer diseases.
Our DataBridge platform
Data is the foundation for medical research. For rare cancers this data is scarce and scattered.
Via our DataBridge platform we focus on collecting:
We believe that with a state of the art platform we can provide the necessary foundation for comprehensive research
Integration
Collect data across multiple sources & medical institutions
Research Catalog
Easily discover and request data amongst various sources
Automation
Automate time intensive processes and facilitate re-use
Governance & Compliance
Out of the box governance processes to comply with rules and regulations
Prof. Dr. Henk Verheul
“Multidisciplinary collaboration and the use of innovative technologies like artificial intelligence on large medical databases in cancer medicine will undoubtedly contribute to better treatment outcomes for cancer patients. I am extremely pleased that Yamicc has been established to support this type of research.”
Prof. Dr. Henk Verheul
Prof. Dr. C.M.F. (Clemens) Dirven
“Yamicc encourages research, application of experimental treatments, and data collection for patients with rare forms of cancer. This provides researchers with not only significantly more data, but also more comprehensive and higher-quality information to discover new treatments”